Edition:
United States

ChemoCentryx Inc (CCXI.OQ)

CCXI.OQ on NASDAQ Stock Exchange Global Select Market

11.10USD
10:38am EDT
Change (% chg)

$-0.31 (-2.72%)
Prev Close
$11.41
Open
$11.39
Day's High
$11.39
Day's Low
$10.82
Volume
7,174
Avg. Vol
87,033
52-wk High
$15.08
52-wk Low
$5.45

Chart for

About

ChemoCentryx, Inc. is a biopharmaceutical company. The Company is engaged in developing new medications targeted at inflammatory disorders, autoimmune diseases and cancer. Each of its drug candidates focuses on a specific chemoattractant receptor that selectively blocks its negative inflammatory or suppressive response, leaving... (more)

Overall

Beta: 1.76
Market Cap(Mil.): $536.03
Shares Outstanding(Mil.): 50.38
Dividend: --
Yield (%): --

Financials

  CCXI.OQ Industry Sector
P/E (TTM): 38.76 29.75 32.14
EPS (TTM): 0.27 -- --
ROI: 14.38 13.18 12.83
ROE: 48.14 15.14 14.95

BRIEF-Vifor Pharma Increases Equity Investment In ChemoCentryx

* INCREASES EQUITY STAKE IN CHEMOCENTRYX FROM 6.6% TO 21.2% Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Sep 18 2018

BRIEF-Chemocentryx Q1 Revenue $9.5 Million Versus $8.2 Million

* CHEMOCENTRYX REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND RECENT HIGHLIGHTS

May 09 2018

Competitors

Earnings vs. Estimates